Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

NCT01809301 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Niaspan
DRUG: TRIA-662

Sponsor

Cortria Corporation

Collaborators

[object Object]
[object Object]